1,839 research outputs found

    Effect of electric field/current on liquid phase sintering

    Get PDF
    Sintering behavior of ionic and electric conductor ceramics is enhanced when an external electric field is applied during the sintering process by Joule heating, generation of Frenkel defects, mobility of point defects, electrochemical reactions and electromigration mechanisms. The applied electric field modifies the sintering behavior in two ways, depending mainly on the strength of the field (V/cm) and the electrical properties of the sample. Intermediate fields enhance the sintering kinetics apparently due to the retardation of grain growth, which is called field assisted sintering. In contrast, high fields generate massive densification just in few seconds, which is recently referenced as flash sintering. Nonetheless, the majority of these studies are performed for solid state sintering (SS), whereas only a few works have been published on liquid phase sintering (LPS). In this work, the effect of the electric field on liquid phase sintering is analyzed in detail, being the first time that flash sintering is observed in LPS. Alumina containing different amount of a glassy phase (Al2O3/CAS) was chosen to ascertain the role of current on liquid phase sintering using a sinter-forging device. In situ laser dilatometry, evaluation of specimen temperature, real-time measurement of electrical field and current density are complemented by microstructure analysis and sintering rates calculations, which give insights of involved mechanisms as function of the sintering conditions and applied field. In addition, viscosity measurements and wettability studies of the glass at high temperature were carried out to reveal the effect of current on the response of glass. Current flowed only through the liquid phase at high temperature and enhanced the densification process by two effects: Joule heating and athermal response of the viscous liquid under the electric field. Joule heating increased the temperature within the specimen, whereas the applied electric field reduced the viscosity of the liquid phase promoting a more effective matter transport

    Use of metallurgical residues as potential raw materials for high performance refractory castables

    Get PDF
    The steelmaking industry generates several by-products during the different stages of steel production. As a by-product, vanadium slag account for more than 60% of the world’s overall production. However, it is tough to find vanadium in its pure state as it occurs in combination with various minerals. Using secondary resources for refractory castables solves the issue of natural raw materials, reduces costs related to their extraction and processing, and is friendly to the environment

    MAX phases as candidates for Concentrated Solar Power receivers

    Full text link
    New generation concentrated solar power (CSP) plants require new solar receiver materials with selective optical properties and excellent corrosion resistance against molten salts. MAX phases are promising materials for CSP applications due to their optical properties and resistance to extreme environments. Herein, we report a solar absorptance above or equal to 0.5 and a thermal emittance of 0.17-0.31 between 600 and 1500 K for Cr2AlC, Ti2AlC, and Ti3AlC2. These compositions were also exposed to solar salt corrosion at 600 {\deg}C for up to 4 weeks. Cr2AlC exhibited a superior corrosion resistance due to the formation of a protective nanometric layer.Comment: 19 pages, 5 figures, 1 tabl

    Mechanical characterisation of the protective Al2O3 scale in Cr2AlC MAX phases

    Get PDF
    MAX phases have great potential under demands of both high-temperature and high-stress performance, with their mixed atomic bonding producing the temperature and oxidation resistance of ceramics with the mechanical resilience of metals. Please click Additional Files below to see the full abstract

    Phase transition at 350 K in the Ti3_3C2_2Tx_x MXene: possible sliding (moir\'e) ferroelectricity

    Full text link
    A phase transition is found in Ti3_3C2_2Tx_x MXene at 350 K, by measuring the complex Young's modulus of self-standing thick films. A step-like softening and increase of the mechanical losses is found below 350 K, indicative of a phase transition, where the square of the order parameter is coupled to strain. It is argued that it should be a ferroelectric transition, most likely of the sliding (moir\'e) type, due to charge transfer between facing flakes sliding with respect to each other. If the transition will be confirmed to be ferroelectric, Ti3_3C2_2Tx_x will be added to the class of metallic ferroelectrics and open new perspectives of applications, in addition to the numerous already studied

    Decoration of laser induced graphene with MXene and manganese oxide for fabrication of a hybrid supercapacitor

    Get PDF
    During the last years, Internet of Things has become a prominent topic of technical, social, and economic importance. One of the main consequences is the high demand for energy and power density from small energy storage devices. In this field the laser induced graphene (LIG) has become a promising material to produce flexible micro-supercapacitors. The issue with this material is that the performances are strongly restrained by its limited surface area and the relatively low conductivity. In this work we improve the performance of a LIG supercapacitor by decorating its surface through electrophoresis: one electrode will be decorated with metal nitrides and metal carbides (MXenes), the other with manganese oxide. These two materials have appreciable conductivity and pseudocapacitance. Electrochemical measurements have been carried out on the two electrodes separately. After a charge balancing, the device has been sealed in pouch and tested

    Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria

    Get PDF
    Albuminuria is an indicator of cardiovascular risk and renal damage in hypertensive individuals. Chronic renin-angiotensin system (RAS) suppression facilitates blood pressure control and prevents development of new-onset-albuminuria. A significant number of patients, however, develop albuminuria despite chronic RAS blockade, and the physiopathological mechanisms are underexplored. Urinary exosomes reflect pathological changes taking place in the kidney. The objective of this work was to examine exosomal protein alterations in hypertensive patients with albuminuria in the presence of chronic RAS suppression, to find novel clues underlying its development. Patients were followed-up for three years and were classified as: a) patients with persistent normoalbuminuria; b) patients developing de novo albuminuria; and c) patients with maintained albuminuria. Exosomal protein alterations between groups were identified by isobaric tag quantitation (iTRAQ). Confirmation was approached by target analysis (SRM). In total, 487 proteins were identified with high confidence. Specifically, 48 proteins showed an altered pattern in response to hypertension and/or albuminuria. Out of them, 21 proteins interact together in three main functional clusters: glycosaminoglycan degradation, coagulation and complement system, and oxidative stress. The identified proteins constitute potential targets for drug development and may help to define therapeutic strategies to evade albuminuria progression in hypertensive patients chronically treated.Instituto de Salud Carlos III, fondos FEDER/FSE (PI11/01401, PI13/01873, PI14/01841, IF08/3667-1, PI11-02239, PI 14/0917, PI11/02432, PI13/01746, PI14/01650, PI16/01334, PT13/0001/0013, CP09/00229, CP15/00129, CPII15/00027), Fundacion SENEFRO, Fundacion Conchita Rabago de Jimenez Diaz, and Redes Tematicas de Investigacion Cooperativa (fondos FEDER/FSE, RD12/0021/0001, RD12/0042/0071). These results are lined up with the Spanish initiative on the Human Proteome Project (SpHPP).S

    Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation

    Get PDF
    BACKGROUND: Psoriasis is a frequent inflammatory skin disease that is mainly mediated by IL-23, IL-1β, and IL-17 cytokines. Although psoriasis is a hyperproliferative skin disorder, the possible role of amino acid transporters has remained unexplored. OBJECTIVE: We sought to investigate the role of the essential amino acid transporter L-type amino acid transporter (LAT) 1 (SLC7A5) in psoriasis. METHODS: LAT1 floxed mice were crossed to Cre-expressing mouse strains under the control of keratin 5, CD4, and retinoic acid receptor-related orphan receptor γ. We produced models of skin inflammation induced by imiquimod (IMQ) and IL-23 and tested the effect of inhibiting LAT1 (JPH203) and mammalian target of rapamycin (mTOR [rapamycin]). RESULTS: LAT1 expression is increased in keratinocytes and skin-infiltrating lymphocytes of psoriatic lesions in human subjects and mice. LAT1 deletion in keratinocytes does not dampen the inflammatory response or their proliferation, which could be maintained by increased expression of the alternative amino acid transporters LAT2 and LAT3. Specific deletion of LAT1 in γδ and CD4 T cells controls the inflammatory response induced by IMQ. LAT1 deletion or inhibition blocks expansion of IL-17-secreting γ4+δ4+ and CD4 T cells and dampens the release of IL-1β, IL-17, and IL-22 in the IMQ-induced model. Moreover, inhibition of LAT1 blocks expansion of human γδ T cells and IL-17 secretion by human CD4 T cells. IL-23 and IL-1β stimulation upregulates LAT1 expression and induces mTOR activation in IL-17+ γδ and TH17 cells. Deletion or inhibition of LAT1 efficiently controls IL-23- and IL-1β-induced phosphatidylinositol 3-kinase/AKT/mTOR activation independent of T-cell receptor signaling. CONCLUSION: Targeting LAT1-mediated amino acid uptake is a potentially useful immunosuppressive strategy to control skin inflammation mediated by the IL-23/IL-1β/IL-17 axis.Funding This manuscript has been funded by grants SAF 2017-82886-R (FS-M) and SAF 2013-42850-R (MF) from the Spanish Ministry of Economy and Competitiveness; CAM (S2017/BMD-3671-INFLAMUNE-CM) from the Comunidad de Madrid (FS-M); CIBERCV, BIOIMID PIE13/041 from Instituto de Salud Carlos III and Fundación La Marató TV3 (20152330 31). The project leading to these results has also received funding from FUNDACIÓN BBVA A EQUIPOS DE INVESTIGACIÓN CIENTÍFICA 2018 and from “la Caixa” Banking Foundation under the project code HR17-00016 (FS-M), and from Agencia Estatal de Investigación, Fondo Europeo de Desarrollo Regional PI17/01972 (E.D).S

    Plasma Molecular Signatures in Hypertensive Patients With Renin-Angiotensin System Suppression: New Predictors of Renal Damage and De Novo Albuminuria Indicators

    Get PDF
    Albuminuria is a risk factor strongly associated with cardiovascular disease, the first cause of death in the general population. It is well established that renin-angiotensin system suppressors prevent the development of new-onset albuminuria in naïf hypertensive patients and diminish its excretion, but we cannot forget the percentage of hypertensive patients who develop de novo albuminuria. Here, we applied multiple proteomic strategy with the purpose to elucidate specific molecular pathways involved in the pathogenesis and provide predictors and chronic organ damage indicators. Briefly, 1143 patients were followed up for a minimum period of 3 years. One hundred and twenty-nine hypertensive patients chronically renin-angiotensin system suppressed were recruited, classified in 3 different groups depending on their albuminuria levels (normoalbuminuria, de novo albuminuria, and sustained albuminuria), and investigated by multiple proteomic strategies. Our strategy allowed us to perform one of the deepest plasma proteomic analysis to date, which has shown 2 proteomic signatures: (1) with predictive value of de novo albuminuria and (2) sustained albuminuria indicator proteins. These proteins are involved in inflammation, immune as well as in the proteasome activation occurring in situations of endoplasmic reticulum stress. Furthermore, these results open the possibility of a future strategy based on anti-immune therapy to treat hypertension which could help to prevent the development of albuminuria and, hence, the progression of kidney damage.N

    Clinical Heterogeneity of Pulmonary Arterial Hypertension Associated With Variants in TBX4

    Get PDF
    Background: The knowledge of hereditary predisposition has changed our understanding of Pulmonary Arterial Hypertension. Genetic testing has been widely extended and the application of Pulmonary Arterial Hypertension specific gene panels has allowed its inclusion in the diagnostic workup and increase the diagnostic ratio compared to the traditional sequencing techniques. This is particularly important in the differential diagnosis between Pulmonary Arterial Hypertension and Pulmonary Venoocclusive Disease. Methods: Since November 2011, genetic testing is offered to all patients with idiopathic, hereditable and associated forms of Pulmonary Arterial Hypertension or Pulmonary Venoocclusive Disease included in the Spanish Registry of Pulmonary Arterial Hypertension. Herein, we present the clinical phenotype and prognosis of all Pulmonary Arterial Hypertension patients with disease-associated variants in TBX4. Results: Out of 579 adults and 45 children, we found in eight patients from seven families, disease-causing associated variants in TBX4. All adult patients had a moderate-severe reduction in diffusion capacity. However, we observed a wide spectrum of clinical presentations, including Pulmonary Venoocclusive Disease suspicion, interstitial lung disease, pulmonary vascular abnormalities and congenital heart disease. Conclusions: Genetic testing is now essential for a correct diagnosis work-up in Pulmonary Arterial Hypertension. TBX4-associated Pulmonary Arterial Hypertension has marked clinical heterogeneity. In this regard, a genetic study is extremely useful to obtain an accurate diagnosis and provide appropriate management.This project was founded by Project "Bases Gene´tico Moleculares de la Medicina de Precisio´n en la Hipertensio´n Arterial Pulmonar". Funder: Instituto Carlos III. Ministerio de Economı´a y Competitividad. https://www.isciii.es/Paginas/Inicio.aspx Award number: PI 18/01233 Grant Recipient: P E-
    corecore